These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 27099928)

  • 1. Tick-Host-Pathogen Interactions: Conflict and Cooperation.
    de la Fuente J; Villar M; Cabezas-Cruz A; Estrada-Peña A; Ayllón N; Alberdi P
    PLoS Pathog; 2016 Apr; 12(4):e1005488. PubMed ID: 27099928
    [No Abstract]   [Full Text] [Related]  

  • 2. Tick Bioactive Molecules as Novel Therapeutics: Beyond Vaccine Targets.
    Murfin KE; Fikrig E
    Front Cell Infect Microbiol; 2017; 7():222. PubMed ID: 28634573
    [No Abstract]   [Full Text] [Related]  

  • 3. Subolesin/Akirin vaccines for the control of arthropod vectors and vectorborne pathogens.
    de la Fuente J; Moreno-Cid JA; Galindo RC; Almazan C; Kocan KM; Merino O; Perez de la Lastra JM; Estrada-Peña A; Blouin EF
    Transbound Emerg Dis; 2013 Nov; 60 Suppl 2():172-8. PubMed ID: 24589118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting arthropod subolesin/akirin for the development of a universal vaccine for control of vector infestations and pathogen transmission.
    de la Fuente J; Moreno-Cid JA; Canales M; Villar M; de la Lastra JM; Kocan KM; Galindo RC; Almazán C; Blouin EF
    Vet Parasitol; 2011 Sep; 181(1):17-22. PubMed ID: 21561715
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vaccination with proteins involved in tick-pathogen interactions reduces vector infestations and pathogen infection.
    Merino O; Antunes S; Mosqueda J; Moreno-Cid JA; Pérez de la Lastra JM; Rosario-Cruz R; Rodríguez S; Domingos A; de la Fuente J
    Vaccine; 2013 Dec; 31(49):5889-96. PubMed ID: 24084474
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Host immunity to ticks.
    Wikel SK
    Annu Rev Entomol; 1996; 41():1-22. PubMed ID: 8546443
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospects for vaccination against the ticks of pets and the potential impact on pathogen transmission.
    de la Fuente J; Villar M; Contreras M; Moreno-Cid JA; Merino O; Pérez de la Lastra JM; de la Fuente G; Galindo RC
    Vet Parasitol; 2015 Feb; 208(1-2):26-9. PubMed ID: 25555312
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tick immunobiology.
    Brossard M; Wikel SK
    Parasitology; 2004; 129 Suppl():S161-76. PubMed ID: 15940820
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The antiviral immunity of ticks against transmitted viral pathogens.
    Talactac MR; Hernandez EP; Hatta T; Yoshii K; Kusakisako K; Tsuji N; Tanaka T
    Dev Comp Immunol; 2021 Jun; 119():104012. PubMed ID: 33484780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How ticks keep ticking in the adversity of host immune reactions.
    Jennings R; Kuang Y; Thieme HR; Wu J; Wu X
    J Math Biol; 2019 Apr; 78(5):1331-1364. PubMed ID: 30478760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ANTIDotE: anti-tick vaccines to prevent tick-borne diseases in Europe.
    Sprong H; Trentelman J; Seemann I; Grubhoffer L; Rego RO; Hajdušek O; Kopáček P; Šíma R; Nijhof AM; Anguita J; Winter P; Rotter B; Havlíková S; Klempa B; Schetters TP; Hovius JW
    Parasit Vectors; 2014 Feb; 7():77. PubMed ID: 24559082
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Target validation of highly conserved Amblyomma americanum tick saliva serine protease inhibitor 19.
    Kim TK; Radulovic Z; Mulenga A
    Ticks Tick Borne Dis; 2016 Apr; 7(3):405-14. PubMed ID: 26746129
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The case for oxidative stress molecule involvement in the tick-pathogen interactions -an omics approach.
    Hernandez EP; Talactac MR; Fujisaki K; Tanaka T
    Dev Comp Immunol; 2019 Nov; 100():103409. PubMed ID: 31200008
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of saliva in tick/host interactions.
    Ribeiro JM
    Exp Appl Acarol; 1989 Jun; 7(1):15-20. PubMed ID: 2667917
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Control of tick infestations and pathogen prevalence in cattle and sheep farms vaccinated with the recombinant Subolesin-Major Surface Protein 1a chimeric antigen.
    Torina A; Moreno-Cid JA; Blanda V; Fernández de Mera IG; de la Lastra JM; Scimeca S; Blanda M; Scariano ME; Briganò S; Disclafani R; Piazza A; Vicente J; Gortázar C; Caracappa S; Lelli RC; de la Fuente J
    Parasit Vectors; 2014 Jan; 7():10. PubMed ID: 24398155
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting the tick-pathogen interface for novel control strategies.
    de la Fuente J; Kocan KM; Almazan C; Blouin EF
    Front Biosci; 2008 May; 13():6947-56. PubMed ID: 18508707
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of the tick-pathogen interface by quantitative proteomics.
    Villar M; Popara M; Bonzón-Kulichenko E; Ayllón N; Vázquez J; de la Fuente J
    Ticks Tick Borne Dis; 2012 Jun; 3(3):154-8. PubMed ID: 22647712
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tick modulation of host immunity: an important factor in pathogen transmission.
    Wikel SK
    Int J Parasitol; 1999 Jun; 29(6):851-9. PubMed ID: 10480722
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tick modulation of host cytokines.
    Wikel SK
    Exp Parasitol; 1996 Nov; 84(2):304-9. PubMed ID: 8932782
    [No Abstract]   [Full Text] [Related]  

  • 20. Tick saliva in anti-tick immunity and pathogen transmission.
    Kovár L
    Folia Microbiol (Praha); 2004; 49(3):327-36. PubMed ID: 15259776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.